HU group

(n = 61)

NU group

(n = 141)

p

Known hypertension, n (%)

47 (77.0)

100 (70.9)

0.467

Associated cardiovascular risk factors, n (%)

- diabetes

8 (13.1)

13 (9.2)

0.219

- glucose intolerance

7 (11.5)

8 (5.7)

0.071

- dyslipidemia

28 (45.9)

60 (44.7)

0.873

- overweight/obesity

42 (68.8)

65 (46.1)

0.003

- abdominal obesity

38 (62.3)

96 (68.1)

0.424

- metabolic syndrome

26 (42.6)

55 (39.0)

0.021

- tobacco use

4 (6.5)

9 (6.4)

1

Factors predisposing with the hyperuricemia, n (%)

- neoplasia

2 (3.3)

0 (0)

0.031

- chemotherapy

1 (0.7)

0 (0)

0.127

- alcohol consumption

17 (27.8)

51 (36.2)

0.325

Complications of hypertension, n (%)

- left ventricular hypertrophy

12 (19.7)

16 (11.3)

0.181

- heart failure

19 (31.0)

35 (25.0)

0.131

- stroke

5 (8.0)

44 (31.0)

0.071

- renal insufficiency

33 (54.0)

62 (44.0)

0.098

Therapeutic classes used, n (%)

- thiazides

44 (72.1)

67 (47.5)

0.002

- calcium antagonists

42 (68.8)

96 (68.1)

1

- ACEi/ARBs

40 (65.6)

89 (63.1)

0.862

- betablockers

16 (26.2)

21 (14.9)

0.086

- spironolactone

4 (6.6)

3 (2.1)

0.092

Controlled hypertension, n (%)

19 (31.2)

72 (51.1)

0.01